Search

Your search keyword '"Jackson, Summer"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Jackson, Summer" Remove constraint Author: "Jackson, Summer"
50 results on '"Jackson, Summer"'

Search Results

3. (Not) Paying for Diversity: Repugnant Market Concerns Associated with Transactional Approaches to Diversity Recruitment.

5. A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

7. sj-pdf-1-asq-10.1177_00018392231183649 – Supplemental material for (Not) Paying for Diversity: Repugnant Market Concerns Associated with Transactional Approaches to Diversity Recruitment

10. Gender and Criminal Justice Responses to Terrorism in the United States.

12. Triadic Advocacy Work

13. Troubleshooting Violence: An Evaluation of Ghost Guns, Firearm-Related Violence, and Law Enforcement Policy in a Bay Area city.

21. From Surviving to Thriving With Work Innovations: New Perspectives on Coping with Work & Technology.

23. Abstract LB-240: Circulating tumor cell (CTC) analysis in NRG oncology/RTOG 1014, repeat breast conserving treatment after in-breast recurrence (IBR)

24. Open-label phase Ib study of entinostat (E), and lapatinib (L) alone, and in combination with trastuzumab (T) in patients (pts) with HER2+ metastatic (mHER2+) breast cancer after progression on trastuzumab.

25. EpCAM-independent isolation of EMT- circulating tumor cells in patients with primary breast cancer who receive primary systemic therapy.

26. Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer

27. Abstract OT1-1-15: A phase II study of dovitinib as salvage therapy in patients with stage IV inflammatory breast cancer HER2-negative with local or distant relapse

28. Abstract P5-19-22: A phase I clinical trial of entinostat and lapatinib in patients with trastuzumab refractory HER2-positive metastatic breast cancer

29. Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.

30. Firms, Occupations, and Markets as Tools for Combating Systemic Racism: Challenges and Opportunities.

31. How Can organizations achieve their diversity goals? New theories and evidence.

32. Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination

33. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

34. Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

38. Abstract LB-314: Patients with inflammatory breast cancer have significant reductions in immune cells responsible for adaptive immunity

41. Circulating Tumor Cells and [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Outcome Prediction in Metastatic Breast Cancer

43. Circulating Tumor Cells in Metastatic Breast Cancer: Biologic Staging Beyond Tumor Burden

44. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

45. An Occupational Lens on Social Inequality.

46. Not Paying for Diversity: Repugnant Concerns with Instrumental Approaches to Diversity Recruitment.

47. Building Diverse, Equitable, and Inclusive Workplaces: What Works? What Doesn't? And Why?

48. Have They Said Something? Examining Changes in Citizen Reporting of Possible Terrorism to the Police

49. Measuring Intervention Success in Countering Terrorism

50. Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination

Catalog

Books, media, physical & digital resources